Pneumococcal colonization in older adults

详细信息    查看全文

• 作者：Susanna Esposito ; Daniela Mari ; Luigi Bergamaschini ; Annalisa Orenti…
• 关键词：Invasive pneumococcal disease ; Pneumococcal carriage ; Pneumococcal colonization ; 13 ; valent pneumococcal conjugate vaccine ; 23 ; valent polysaccharide pneumococcal vaccine ; 13 ; valent pneumococcal vaccine ; Pneumococcal vaccination ; Prevention ; Streptococcus pneumoniae
• 刊名：Immunity & Ageing
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：13
• 期：1
• 全文大小：468 KB
• 参考文献：1.Centers for Disease Control and Prevention. Vaccines and immunizations. Chapter 11: Pneumococcal. Manual for the surveillance of vaccine-preventable diseases. Available at: http://​www.​cdc.​gov/​vaccines/​pubs/​surv-manual/​chpt11-pneumo.​html . Accessed on: September 29, 2015.
  2.Liao WH, Lin SH, Lai CC, Tan CK, Liao CH, Huang YT, et al. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis. 2010;29:489–92.PubMed CrossRef
  3.Helferty M, Rotondo JL, Martin I, Desai S. The epidemiology of invasive pneumococcal disease in the Canadian North from 1999 to 2010. Int J Circumpolar Health. 2013;72:21606.CrossRef
  4.Elberse KE, van der Heide HG, Witteveen S, van de Pol I, Schot CS, van der Ende A, et al. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine. Vaccine. 2012;30:7644–51.PubMed CrossRef
  5.Improving global health by preventing pneumococcal disease. In: All-party parliamentary group on pneumococcal disease prevention in the developing world, 2008. Available at: http://​www.​appg-preventpneumo.​org.​uk/​download/​appg_​report.​pdf . Accessed on October 9, 2015.
  6.José RJ, Periselneris JN, Brown JS. Community-acquired pneumonia. Curr Opin Pulm Med. 2015;21:212–8.PubMed CrossRef
  7.Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372:1114–25.PubMed CrossRef
  8.Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL, et al. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11:841–55.PubMed CrossRef
  9.Davis SM, Deloria-Knoll M, Kassa HT, O'Brien KL. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine. 2013;32:133–45.PubMed CrossRef
  10.Esposito S, Principi N. Impacts of the 13-valent pneumococcal conjugate vaccine in children. J Immunol Res. 2015;2015:591580.PubMed PubMedCentral
  11.Centers for Disease Control and Prevention. Pneumococcal disease. Available at: http://​www.​cdc.​gov/​pneumococcal/​vaccination.​html . Accessed on: September 29, 2015.
  12.O’Brien KL, Nohynek H, World Health Organization Pneumococcal Vaccine Trials Carriage Working Group. Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003;22:133–40.PubMed
  13.Principi N, Terranova L, Zampiero A, Manzoni F, Senatore L, Rios WP, et al. Oropharyngeal and nasopharyngeal sampling for the detection of adolescent Streptococcus pneumoniae carriers. J Med Microbiol. 2014;63:393–8.PubMed CrossRef
  14.Trzciński K, Bogaert D, Wyllie A, Chu ML, van der Ende A, Bruin JP, et al. Superiority of trans-oral over transnasal sampling in detecting Streptococcus pneumoniae colonization in adults. PLoS One. 2013;8:e60520.PubMed PubMedCentral CrossRef
  15.Carvalho Mda G, Pimenta FC, Moura I, Roundtree A, Gertz Jr RE, Li Z, et al. Non-pneumococcal mitis group streptococci confound detection of pneumococcal capsular serotype specific loci in upper respiratory tract. Peer J. 2013;1:e97.PubMed CrossRef
  16.Cvitkovic Spik V, Beovic B, Pokorn M, Drole Torkar A, Vidmar D, Papst L, et al. Improvement of pneumococcal pneumonia diagnostics by the use of rt-PCR on plasma and respiratory samples. Scand J Infect Dis. 2013;45:731–7.PubMed CrossRef
  17.Azzari C, Moriondo M, Indolfi G, Cortimiglia M, Canessa C, Becciolini L, et al. Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One. 2010;5:e9282.PubMed PubMedCentral CrossRef
  18.Dube FS, Kaba M, Whittaker E, Zar HJ, Nicol MP. Detection of Streptococcus pneumoniae from different types of nasopharyngeal swabs in children. PLoS One. 2013;8:e68097.PubMed PubMedCentral CrossRef
  19.Ridda I, Macintyre CR, Lindley R, McIntyre PB, Brown M, Oftadeh S, et al. Lack of pneumococcal carriage in the hospitalised elderly. Vaccine. 2010;28:3902–4.PubMed CrossRef
  20.Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med. 2011;8:e1001017.PubMed PubMedCentral CrossRef
  21.Palmu AA, Kaijalainen T, Saukkoriipi A, Leinonen M, Kilpi TM. Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen testing healthy elderly subjects. Scand J Infect Dis. 2012;44:433–8.PubMed CrossRef
  22.da Gloria CM, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, Millar EV, et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol. 2010;48:1611–8.CrossRef
  23.Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44:124–31.PubMed PubMedCentral CrossRef
  24.Adetifa IM, Antonio M, Okoromah CA, Ebruke C, Inem V, Nsekpong D, et al. Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology. PLoS One. 2012;7:e30548.PubMed PubMedCentral CrossRef
  25.Turner P, Turner C, Jankhot A, Helen N, Lee SJ, Day NP, et al. A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border. PLoS One. 2012;7:e38271.PubMed PubMedCentral CrossRef
  26.Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R, Perilla MJ, et al. Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis. 2012;205:280–8.PubMed PubMedCentral CrossRef
  27.Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, et al. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis. 2006;193:1487–94.PubMed CrossRef
  28.Krone CL, Wyllie AL, van Beek J, Rots NY, Oja AE, Chu ML, et al. Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness. PLoS One. 2015;10:e0119875.PubMed PubMedCentral CrossRef
  29.Ansaldi F, de Florentiis D, Canepa P, Ceravolo A, Rappazzo E, Iudici R, et al. Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation. Hum Vaccin Immunother. 2013;9:614–20.PubMed PubMedCentral CrossRef
  30.Principi N, Terranova L, Zampiero A, Montinaro V, Ierardi V, Peves Rios W, et al. Pharyngeal colonization by Streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage. Pediatr Infect Dis J. 2015;34:426–32.PubMed CrossRef
  31.Andrews NJ, Waight PA, Burbidge P, Pearce E, Roalfe L, Zancolli M, et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14:839–46.PubMed CrossRef
  32.Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15:535–43.PubMed CrossRef
  33.Russell FM, Carapetis JR, Satzke C, Tikoduadua L, Waqatakirewa L, Chandra R, et al. Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster. Clin Vaccine Immunol. 2010;17:1970–6.PubMed PubMedCentral CrossRef
  34.Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822–5.PubMed
  35.Pimenta FC, Roundtree A, Soysal A, Bakir M, du Plessis M, Wolter N, et al. Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol. 2013;51:647–52.PubMed PubMedCentral CrossRef
  36.Pasinato A, Indolfi G, Marchisio P, Valleriani C, Cortimiglia M, Spanevello V, et al. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR. Vaccine. 2014;32:1375–81.PubMed CrossRef
  37.Tarragó D, Fenoll A, Sánchez-Tatay D, Arroyo LA, Muñoz-Almagro C, Esteva C, et al. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect. 2008;14:828–34.PubMed CrossRef
  
• 作者单位：Susanna Esposito (1)
  Daniela Mari (2)
  Luigi Bergamaschini (3)
  Annalisa Orenti (4)
  Leonardo Terranova (1)
  Luca Ruggiero (1)
  Valentina Ierardi (1)
  Monia Gambino (1)
  Francesco Della Croce (5)
  Nicola Principi (1)
  
  1. Department of Pathophysiology and Transplantation, Pediatric Highly Intensive Care Unit, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122, Milan, Italy
  2. Department of Medical Sciences and Community Health, Geriatric Unit, Università degli Studi di Milano, Milan, Italy
  3. Department of Biomedical and Clinical Sciences “Luigi Sacco”, Università degli Studi di Milano, Milan, Italy
  4. Department of Clinical Sciences and Community Health, Laboratory of Medical Statistics, Epidemiology and Biometry “G.A. Maccacaro”, Università degli Studi di Milano, Milan, Italy
  5. ASP, Pio Albergo Trivulzio, Milan, Italy
  
• 刊物主题：Immunology; Geriatrics/Gerontology; Aging;
• 出版者：BioMed Central
• ISSN：1742-4933

文摘

Background Little is known about pneumococcal carrier states in older adults. The main aim of this study was to evaluate pneumococcal colonization patterns among older adults in two centres in Milan, Italy, before the widespread use of the 13-valent pneumococcal vaccine (PCV13) in this age group, to investigate demographic and clinical features that are associated with pneumococcal colonization and to estimate the potential coverage offered by PCV13.